Volume 13, Issue 5 pp. 600-619
Basic Science Review

CCFA Microbial–Host Interactions Workshop: Highlights and key observations

R. Balfour Sartor MD

Corresponding Author

R. Balfour Sartor MD

University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

R. Balfour Sartor, MD, is the Chairperson of the Workshop Organizing Committee. Workshop sponsored by the Crohn's & Colitis Foundation of America, and supported in part by an unrestricted educational grant from UCB Pharma.

c/o Marjorie Merrick, Vice President of Research and Scientific Programs, Crohn's & Colitis Foundation of America, 386 Park Avenue South, 17th Floor, New York, New York 10016. E-mail: [email protected]Search for more papers by this author
Richard S. Blumberg MD

Richard S. Blumberg MD

Brigham & Women's, Hospital, Boston, Massachusetts

Search for more papers by this author
Jonathan Braun MD, PhD

Jonathan Braun MD, PhD

University of California at Los Angeles, Los Angeles, California

Search for more papers by this author
Charles O. Elson MD

Charles O. Elson MD

University of Alabama at Birmingham, Birmingham, Alabama

Search for more papers by this author
Lloyd F. Mayer MD

Lloyd F. Mayer MD

Mount Sinai School of Medicine, New York, New York

Search for more papers by this author
First published: 09 February 2007
Citations: 1

Abstract

This article provides a summary of the proceedings of the CCFA Microbial–Host Interactions Workshop that was held in St. Petersburg, Florida, on March 16–19, 2006. Approximately 75 senior and junior investigators from around the world shared their most current research findings through oral presentations, poster sessions, and active discussion. Because intestinal microbiota are significant contributors in the development of inflammatory bowel diseases (IBD), understanding the body's responses to and interactions with microbes, especially in the colon and distal small intestine, is critical to elucidating the etiology and pathogenesis of IBD and developing effective therapeutic interventions. Major advances have occurred recently in molecular detection of luminal bacterial species, identifying dominant microbial antigens that drive intestinal inflammation, the mechanisms of innate immune and epithelial responses to bacteria, and regulation of inflammation by innate and acquired immune cells.

(Inflamm Bowel Dis 2007)

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.